These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 3833348)

  • 21. [Isoptin Retard. Pharmacokinetics and pharmacodynamics in patients with angina pectoris].
    Jespersen CM
    Ugeskr Laeger; 1990 May; 152(21):1516-8. PubMed ID: 2193448
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential index: a simple time domain heart rate variability analysis with prognostic implications in stable angina pectoris.
    Bjorkander I; Forslund L; Kahan T; Ericson M; Held C; Rehnqvist N; Hjemdahl P
    Cardiology; 2008; 111(2):126-33. PubMed ID: 18376124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term safety of a novel antianginal agent in patients with severe chronic stable angina: the Ranolazine Open Label Experience (ROLE).
    Koren MJ; Crager MR; Sweeney M
    J Am Coll Cardiol; 2007 Mar; 49(10):1027-34. PubMed ID: 17349881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Evaluation of antianginal efficacy of long-term therapy with low dose isosorbide dinitrate in patients with stable angina pectoris].
    Kośmicki M; Sadowski Z
    Przegl Lek; 2000; 57(9):455-8. PubMed ID: 11199864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Possibility of developing tolerance to the antianginal effect of verapamil].
    Shakarova SSh; Martsevich SIu; Metelitsa VI; Vygodin VA; Strel'tsov AA
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1984; 7(2):75-8. PubMed ID: 6508932
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical relevance of verapamil plasma levels in stable angina pectoris.
    Frishman W; Kirsten E; Klein M; Pine M; Johnson SM; Hillis LD; Packer M; Kates R
    Am J Cardiol; 1982 Nov; 50(5):1180-4. PubMed ID: 6753558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Long-term study with Stenoptin in general practice].
    Kessler H
    Med Welt; 1980 Jan; 31(4):149-51. PubMed ID: 6154224
    [No Abstract]   [Full Text] [Related]  

  • 28. [Relation of the anti-anginal effect and blood serum level of verapamil in patients with exercise-induced stenocardia].
    Slastnikova ID; Rumiantsev DO; Piotrovskiĭ VK; Metelitsa VI
    Kardiologiia; 1990 Feb; 30(2):20-4. PubMed ID: 2190039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term persistence of antianginal effect of oral verapamil in chronic stable angina.
    Zanolla L; Trevi GP; Rizzo A; Padrini R; Piovan D; Olivieri D; Zardini P
    J Cardiovasc Pharmacol; 1984; 6(3):423-8. PubMed ID: 6202967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of ischemic heart disease in the elderly. Comparison of diltiazem, verapamil and gallopamil].
    Simonelli P; Papa A; Macciocchi B; Auriemma F; Vetrano A; Scaletta Romeo di Santillo M; Ceriello A
    Minerva Cardioangiol; 1993 May; 41(5):193-204. PubMed ID: 8355859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Verapamil in effort angina: a multi-centre study].
    Vincenzi M; Braito E; Cappelletti F; Caponnetto S; De Ponti C; Distante R; Masoni A; Palmieri M; Ricciardelli B; Uslenghi E; Zanini S
    G Ital Cardiol; 1982; 12(9):660-5. PubMed ID: 6820344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma verapamil levels and exercise performance.
    Weiner DA; McCabe CH; Cutler SS; Ryan TJ; Klein MD
    Clin Pharmacol Ther; 1984 Jul; 36(1):25-32. PubMed ID: 6734046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparison of the anti-ischemia effect of nisoldipine and verapamil. Double-blind randomized cross-over and placebo-controlled acute and long-term study].
    Brügmann U; Blasini R; Rudolph W
    Herz; 1984 Aug; 9(4):244-52. PubMed ID: 6434387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma concentration--response relationship of verapamil in the treatment of angina pectoris.
    Anderson P; Bondesson U; Sylvén C; Aström H
    J Cardiovasc Pharmacol; 1982; 4(4):609-14. PubMed ID: 6181335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-anginal effect of oral verapamil: evidence of dose-dependence of the effect.
    Zanolla L; Righetti B; Rossi L; Barbieri E; Sheiban I; Olivieri D; Trevi GP
    G Ital Cardiol; 1983; 13(1):32-8. PubMed ID: 6347788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Verapamil in treatment of chronic stable angina.
    Frishman WH; Charlap S
    Arch Intern Med; 1983 Jul; 143(7):1407-15. PubMed ID: 6135403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The effect of verapamil on the course of stenocardia of effort, on the blood serum lipid level and on the basic indices of carbohydrate metabolism during the long-term use of the preparation].
    Kostko SZ; Abramov AA; Shek AB; Mukhitdinova GN; Galikhanova FA; Levkovich OA
    Kardiologiia; 1992 Jul; 32(7-8):40-2. PubMed ID: 1487877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Value of a calcium antagonist in the long-term treatment of angina pectoris].
    Galinier L
    Sem Hop Ther; 1976; 52(7-8):361-4. PubMed ID: 996554
    [No Abstract]   [Full Text] [Related]  

  • 39. Circadian variation in the pharmacokinetics of verapamil.
    Jespersen CM; Frederiksen M; Hansen JF; Klitgaard NA; Sørum C
    Eur J Clin Pharmacol; 1989; 37(6):613-5. PubMed ID: 2612558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolism of [14C]verapamil.
    McIlhenny HM
    J Med Chem; 1971 Dec; 14(12):1178-84. PubMed ID: 5116230
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.